Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (79) 79
Publication (21) 21
Book / eBook (15) 15
Book Chapter (10) 10
Newspaper Article (4) 4
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (31) 31
male (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
female (18) 18
hematology (18) 18
oncology (18) 18
middle aged (17) 17
rituximab (15) 15
aged (14) 14
chemotherapy (14) 14
adult (12) 12
article (9) 9
lymphoma, large b-cell, diffuse - drug therapy (9) 9
aged, 80 and over (8) 8
animals (8) 8
cancer (8) 8
expression (8) 8
research (8) 8
treatment outcome (8) 8
antibodies, monoclonal - administration & dosage (7) 7
b-cell lymphoma (7) 7
disease-free survival (7) 7
hemic and lymphatic diseases (7) 7
mice (7) 7
non-hodgkin lymphoma (7) 7
therapy (7) 7
trial (7) 7
apoptosis - drug effects (6) 6
cell line, tumor (6) 6
economics (6) 6
follicular lymphoma (6) 6
lymphoma, b-cell - drug therapy (6) 6
mantle cell lymphoma (6) 6
survival (6) 6
abridged index medicus (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
care and treatment (5) 5
chop (5) 5
combined modality therapy (5) 5
doxorubicin (5) 5
economic development (5) 5
lymphoma, large b-cell, diffuse - pathology (5) 5
neoplasm staging (5) 5
non-hodgkin's lymphomas (5) 5
prognosis (5) 5
survival analysis (5) 5
vincristine - administration & dosage (5) 5
xenograft model antitumor assays (5) 5
young adult (5) 5
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, murine-derived - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
apoptosis (4) 4
aurora kinases (4) 4
cell proliferation (4) 4
cell proliferation - drug effects (4) 4
cyclophosphamide - administration & dosage (4) 4
diffuse large b-cell lymphoma (4) 4
doxorubicin - administration & dosage (4) 4
environmental sciences (4) 4
immune system diseases (4) 4
job creation (4) 4
lymphoma (4) 4
lymphoma, b-cell - pathology (4) 4
lymphoma, mantle-cell - drug therapy (4) 4
lymphoma, non-hodgkin - drug therapy (4) 4
lymphoma, non-hodgkin - pathology (4) 4
lymphomas (4) 4
mice, scid (4) 4
non-hodgkins-lymphoma (4) 4
phase-ii (4) 4
prednisone - administration & dosage (4) 4
progression-free survival (4) 4
protein-serine-threonine kinases - antagonists & inhibitors (4) 4
public, environmental & occupational health (4) 4
radioimmunotherapy (4) 4
radiotherapy (4) 4
swog (4) 4
vincristine (4) 4
analysis (3) 3
antibodies, monoclonal, murine-derived (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - pharmacology (3) 3
aurora kinase b (3) 3
azepines - pharmacology (3) 3
combined monoclonal antibody (3) 3
cycling (3) 3
cyclophosphamide - adverse effects (3) 3
diseases (3) 3
docetaxel (3) 3
doxorubicin - adverse effects (3) 3
elderly-patients (3) 3
employment (3) 3
etoposide - therapeutic use (3) 3
genito-urinary organs (3) 3
genitourinary organs (3) 3
health aspects (3) 3
histone deacetylase inhibitor (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
Gerstein Science - Stacks (5) 5
OISE - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
University College (Laidlaw) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Faculty of Information - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Limited-stage DLBCL: It's patient selection
by Persky, Daniel O
Blood, ISSN 0006-4971, 01/2018, Volume 131, Issue 2, pp. 155 - 156
TRIAL | B-CELL LYMPHOMA | SOUTHWEST-ONCOLOGY-GROUP | RITUXIMAB | CHOP | RISK | RADIOTHERAPY | HEMATOLOGY | CHEMOTHERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Limited-stage DLBCL: it’s patient selection
by Persky, Daniel O
Blood, ISSN 0006-4971, 01/2018, Volume 131, Issue 2, pp. 155 - 156
In this issue of Blood , Lamy et al present the results of the LYSA/GOELAMS trial 02-03, where patients with limited-stage diffuse large B-cell lymphoma... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350
by Mahadevan, Daruka and Unger, Joseph M and Spier, Catherine M and Persky, Daniel O and Young, Fay and Leblanc, Michael and Fisher, Richard I and Miller, Thomas P
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 371 - 379
Patients with peripheral T-cell lymphomas (PTCLs) have inferior progression-free survival (PFS) and overall survival (OS) compared with patients who have... 
angioimmunoblastic T-cell lymphoma | not otherwise specified | peripheral T-cell lymphoma | anaplastic lymphoma kinase-negative anaplastic large cell lymphoma | multidrug resistant proteins | chemotherapy | Lymphoma, T-Cell, Peripheral - drug therapy | Deoxycytidine - administration & dosage | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Etoposide - administration & dosage | Male | Treatment Outcome | Cisplatin - administration & dosage | Young Adult | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - metabolism | Lymphoma, T-Cell, Peripheral - pathology | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - mortality | Deoxycytidine - analogs & derivatives | Methylprednisolone - administration & dosage | Antimitotic agents | T cell lymphoma | Patient outcomes | Dosage and administration | Research | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
by Matasar, Matthew J and Luminari, Stefano and Barr, Paul M and Barta, Stefan K and Danilov, Alexey V and Hill, Brian T and Phillips, Tycel J and Jerkeman, Mats and Magagnoli, Massimo and Nastoupil, Loretta J and Persky, Daniel O and Okosun, Jessica
The oncologist, ISSN 1083-7159, 07/2019, p. theoncologist.2019-0138
Follicular lymphoma (FL) is a heterogeneous disease with varying prognosis owing to differences in clinical, laboratory, and disease parameters. Although... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A Phase II, Open-Label Study of Bortezomib (Velcade®), Cladribine, and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas
by Kumar, Abhijeet and Guillen-Rodriguez, Jose and Schatz, Jonathan H and Inclan, Lora and Ayala, Alfonso E and Rivera, Xavier and Sundararajan, Srinath and Anwer, Faiz and Mahadevan, Daruka and Persky, Daniel O and Puvvada, Soham D
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1790 - 1790
Abstract Background: Mantle cell lymphoma (MCL) is characterized by initial sensitivity to both chemotherapy and radiation but also by an invariable relapse... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Sequential RCHOP, Radioimmunotherapy and Rituximab Maintenance Improves Early Outcomes in Advanced Stage Follicular Lymphoma: 5 Year Outcomes from SWOG 0801
by Barr, Paul M and Li, Hongli and Burack, Richard and LeBlanc, Michael and Smith, Sonali M and Gopal, Ajay K and Floyd, Justin D and Persky, Daniel O and Press, Oliver and Fisher, Richard I and Friedberg, Jonathan W
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 614 - 614
Abstract Background: Despite an abundance of effective therapeutic options, advanced stage follicular lymphoma (FL) remains incurable. Further, prospective... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy of Same-Day Vs. Next-Day Pegfilgrastim for the Prevention of Chemotherapy-Induced (Febrile) Neutropenia (CIN/FN): A Meta-Analysis
by Diri, Reem and McBride, Ali and Lee, Christopher and Bagalagel, Alaa and Bakhsh, Hussain and Persky, Daniel O and MacDonald, Karen and Martin, Jennifer and Abraham, Ivo
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4764 - 4764
Abstract Introduction: CIN/FN is a major dose-limiting toxicity of many cancer chemotherapy (CTX) regimens. CIN/FN may require hospitalization, increase... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy
by Mori, Shahram and Patel, Rushang D and Ahmad, Sarfraz and Varela, Juan and Smith, Tori and Altoos, Rola and Shen, Qi and Goldstein, Steven C and Persky, Daniel O
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 02/2019, Volume 19, Issue 2, pp. e93 - e97
. Non-nodal leukemicmantle cell lymphoma (NN-L-MCL) is a relatively uncommon subtype of mantle cell lymphoma (MCL), which is generally considered to be... 
Leukemic | P53 gene mutation | Case report | Non-nodal | Mantle cell lymphoma | PROGNOSIS | TYROSINE KINASE | IBRUTINIB | PHASE-2 | ONCOLOGY | RITUXIMAB | CHOP | MUTATIONS | BCOR | HEMATOLOGY | TP53 | DELETIONS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Potent Efficacy of BCL2 Inhibition with ABT-199 in High-Risk Aggressive B-Lymphoma Models When Combined with Knockdown of MCL1
by Li, Lingxiao and Pongtornpipat, Praechompoo and Tiutan, Timothy and Kendrick, Samantha L and Park, Soyoung and Persky, Daniel O and Rimsza, Lisa M and Puvvada, Soham D and Schatz, Jonathan H
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 506 - 506
Abstract Avoiding apoptosis is a hallmark of cancer. Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and carries a poor prognosis in cases at... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806
by Persky, Daniel O and Li, Hongli and Rimsza, Lisa M and Barr, Paul M and Popplewell, Leslie L and Bane, Charles L and Von Gehr, Ann and Leblanc, Michael and Fisher, Richard I and Smith, Sonali M and Friedberg, Jonathan W
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3931 - 3931
Abstract Background: Loss of major histocompatibility Class II antigens (MHCII) in diffuse large B-cell lymphoma (DLBCL) is associated with a decreased CD8+... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Yttrium-90-Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy After Cytoreduction With ESHAP Chemotherapy In Patients With Relapsed Follicular Non-Hodgkin’s Lymphoma (NHL): Interim Results Of a Phase II Study
by Puvvada, Soham D and Persky, Daniel O and Inclan, Lora and Schatz, Jonathan H and Chase, Ellen M and Guillen, Jose and Roe, D and Miller, Thomas P
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 4404 - 4404
Abstract Background Radioimmunoconjugates are effective treatment in relapsed/refractory follicular lymphoma (FL) when used as single agents, and can result in... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Long Term Follow up of SWOG S0313: Ibritumomab Tiuxetan Consolidation after 3 Cycles of CHOP Plus Radiotherapy for High Risk Limited Stage Aggressive B-Cell Lymphoma
by Persky, Daniel O and Miller, Thomas P and Unger, Joseph M and Spier, Catherine M and Puvvada, Soham D and Stea, B. Dino and Press, Oliver W and Constine, Louis and Barton, Kevin and LeBlanc, Michael and Smith, Sonali and Fisher, Richard I and Friedberg, Jonathan W
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4414 - 4414
Abstract Introduction: Patients with limited stage aggressive B-cell non-Hodgkin lymphoma (LS-NHL) and at least one stage-modified adverse risk factor have an... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Abstract 3684: Targeting Aurora kinase in peripheral T-cell non-Hodgkin's lymphomas
by Mahadevan, Daruka and Qi, Wenqing and Liu, Xiaobing and Cooke, Laurence S and Agarwal, Amit and Persky, Daniel O and Miller, Thomas P
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 3684 - 3684
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) + Rituximab ± Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas
by Kelly, Kevin R and Persky, Daniel O and Mahadevan, Daruka and Miller, Thomas P and Puvvada, Soham D and McDonagh, Kevin and Hayslip, John and Park, Steven I and Ruan, Jia and Rosen, Peter J and Iyer, Swaminathan Padmanabhan and Stefanovic, Alexandra and Zhang, Bin and Zhou, Xiaofei and Ullmann, Claudio Dansky and Leonard, E. Jane and Friedberg, Jonathan W
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3027 - 3027
Abstract Background Amplification and/or over-expression of the mitotic Aurora A kinase (AAK) have been reported in a variety of tumors. The investigational,... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?
by Kumar, Abhijeet and Sundararajan, Srinath and Puvvada, Soham and Persky, Daniel O
Current treatment options in oncology, 09/2016, Volume 17, Issue 9, p. 45
The seminal SWOG trial S8736 trial established the success of a short course of chemotherapy followed by involved field radiation in treating limited stage... 
Humans | Radioimmunotherapy | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Combined Modality Therapy | Prednisone | Lymphoma, Non-Hodgkin - diagnostic imaging | Radiotherapy | Biomarkers, Tumor | Doxorubicin | Vincristine | Disease Progression | Lymphoma, Non-Hodgkin - pathology | Positron Emission Tomography Computed Tomography | Cyclophosphamide | Lymphoma, Non-Hodgkin - therapy | Lymphoma, Non-Hodgkin - mortality | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy
by Mori, Shahram and Patel, Rushang D and Ahmad, Sarfraz and Varela, Juan and Smith, Tori and Altoos, Rola and Shen, Qi and Goldstein, Steven C and Persky, Daniel O
Clinical lymphoma, myeloma & leukemia, 11/2018
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
by Qi, Wenqing and Cooke, Laurence S and Liu, Xiaobing and Rimsza, Lisa and Roe, Denise J and Persky, Ann Manziolli. Daniel O and Miller, Thomas P and Mahadevan, Daruka
Biochemical Pharmacology, ISSN 0006-2952, 2011, Volume 81, Issue 7, pp. 881 - 890
Auroras (A and B) are oncogenic serine/threonine kinases that play key roles in the mitotic phase of the eukaryotic cell cycle. Analysis of the leukemia... 
MLN8237 | Aurora A and B | Mantle cell lymphoma (MCL) | Aurora Inhibitor | Non-Hodgkin lymphoma (NHL) | Docetaxel | SUPPRESSES TUMOR-GROWTH | NON-HODGKINS-LYMPHOMAS | PHASE-II | SPINDLE ASSEMBLY CHECKPOINT | MAMMALIAN-CELLS | CANCER | SMALL-MOLECULE INHIBITOR | MITOTIC SPINDLE | PHARMACOLOGY & PHARMACY | A KINASE | DOSE PACLITAXEL | Taxoids - pharmacology | Apoptosis - drug effects | Pyrimidines - administration & dosage | Humans | Lymphoma, Mantle-Cell - pathology | Aurora Kinases | Pyrimidines - pharmacology | Mice, SCID | Aurora Kinase A | Azepines - pharmacology | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Animals | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Azepines - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Aurora A Inhibitor (MLN8237) plus Vincristine plus Rituximab Is Synthetic Lethal and a Potential Curative Therapy in Aggressive B-cell Non-Hodgkin Lymphoma
by Mahadevan, Daruka and Stejskal, Amy and Cooke, Laurence S and Manziello, Ann and Morales, Carla and Persky, Daniel O and Fisher, Richard I and Miller, Thomas P and Qi, Wenqing
Clinical Cancer Research, ISSN 1078-0432, 04/2012, Volume 18, Issue 8, pp. 2210 - 2219
PURPOSE: Aurora A and B are oncogenic serine/threonine kinases that regulate mitosis. Overexpression of Auroras promotes resistance to microtubule-targeted... 
Cell proliferation | Cell culture | Animal models | Cell survival | Bcl-2 protein | Mitosis | Serine | Clinical trials | Lethality | Gene expression | Vincristine | Cyclin B1 | Lymphocytes B | aurora B protein | Xenografts | mantle cell lymphoma | Protein-serine/threonine kinase | cyclin D1 | Spindles | rituximab | Apoptosis | Cancer | Tumors
Journal Article
Details down arrow
19. Full Text Abstract LB-225: MLN8237 (aurora A inhibitor) plus vincristine plus rituximab is curative in mice bearing aggressive B-cell non-Hodgkin's lymphoma
by Mahadevan, Daruka and Cooke, Laurence S and Stejskal, Amy and Persky, Daniel O and Miller, Thomas P and Qi, Wenqing
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. LB-225 - LB-225
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1
by Li, L and Pongtornpipat, P and Tiutan, T and Kendrick, S.L and Park, S and Persky, D.O and Rimsza, L.M and Puvvada, S.D and Schatz, J.H
Leukemia, ISSN 0887-6924, 08/2015, Volume 29, Issue 8, pp. 1702 - 1712
Better treatments are needed for patients with diffuse large B-cell lymphoma (DLBCL) at high risk of failing standard therapy. Avoiding apoptosis is a hallmark... 
MYC-DRIVEN MOUSE | SURVIVAL | B-CELL LYMPHOMA | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | ONCOLOGY | DOXORUBICIN | DOWN-REGULATION | CHOP | DEPENDENT KINASE INHIBITOR | HEMATOLOGY | MULTIPLE-MYELOMA CELLS | EXPRESSION | Apoptosis - drug effects | Tissue Array Analysis | Humans | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Immunoenzyme Techniques | Proto-Oncogene Proteins c-bcl-2 - metabolism | Female | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | Myeloid Cell Leukemia Sequence 1 Protein - antagonists & inhibitors | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | RNA, Messenger - genetics | Antineoplastic Combined Chemotherapy Protocols | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Drug Synergism | Lymphoma, Large B-Cell, Diffuse - mortality | Xenograft Model Antitumor Assays | Pyridinium Compounds - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Mice, Inbred NOD | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Proto-Oncogene Proteins c-bcl-2 - genetics | Proteins | Chemical inhibitors | Leukemia research | Dosage and administration | Research | Non-Hodgkin's lymphomas | Drug therapy | Health aspects | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.